Evidence map›Paper›PMID 27378147›Full record

ArticleMolecular psychiatry2017

Altered proliferation and networks in neural cells derived from idiopathic autistic individuals.

Maria C Marchetto, Haim Belinson, Yuan Tian, Beatriz C Freitas, Chen Fu, Krishna Vadodaria, Patricia Beltrao-Braga, Cleber A Trujillo, Ana P D Mendes, Krishnan Padmanabhan and 15 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 276 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
276citing papers in PubMed, 2 pooled it
24.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

276 citing papers in PubMed, 2 syntheses or guidelines pooled it, 492 citations in OpenAlex.

  1. Pooled it
  2. Mental health dished up-the use of iPSC models in neuropsychiatric research.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Pooled it
  3. Biological psychiatry global open science · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Diverse excess GABA modes drive autism and epilepsy-autism comorbidity.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Loss of function of the chromatin remodeling geneProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  20. Article

216 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 3 countries.

Maria C Marchetto *The Salk Institute, Laboratory of Genetics, La Jolla, CA 92037, USA.
Haim Belinson *University of California San Francisco, Department of Pediatrics, Institute for Human Genetics, CA 94143, USA.
Yuan TianUniversity of California Los Angeles, Program in Neurogenetics, Department of Neurology, Center for Autism Research and Treatment, Semel Institute, David Geffen School of Medicine, Los Angeles, CA 90402, USA.
Beatriz C FreitasUniversity of California San Diego, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular & Molecular Medicine, Stem Cell Program, La Jolla, CA 92093-0695, USA.
Chen FuCase Western Reserve University, Department of Genetics and Genome Sciences, Cleveland, OH 44106, USA.
Krishna VadodariaThe Salk Institute, Laboratory of Genetics, La Jolla, CA 92037, USA.
Patricia Beltrao-BragaUniversity of California San Diego, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular & Molecular Medicine, Stem Cell Program, La Jolla, CA 92093-0695, USA.
Cleber A TrujilloUniversity of California San Diego, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular & Molecular Medicine, Stem Cell Program, La Jolla, CA 92093-0695, USA.
Ana P D MendesThe Salk Institute, Laboratory of Genetics, La Jolla, CA 92037, USA.
Krishnan PadmanabhanUniversity of Rochester School of Medicine and Dentistry, Department of Neuroscience, 601 Elmwood Avenue, Box 603 Rochester, NY 14642.
Yanelli NunezThe Salk Institute, Laboratory of Genetics, La Jolla, CA 92037, USA.
Jing OuUniversity of California Los Angeles, Program in Neurogenetics, Department of Neurology, Center for Autism Research and Treatment, Semel Institute, David Geffen School of Medicine, Los Angeles, CA 90402, USA.
Himanish GhoshThe Salk Institute, Laboratory of Genetics, La Jolla, CA 92037, USA.
Rebecca WrightThe Salk Institute, Laboratory of Genetics, La Jolla, CA 92037, USA.
Kristen BrennandDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.
Karen PierceUniversity of California San Diego, Department of Neurosciences, La Jolla, CA 92093, USA.
Lawrence EichenfieldUniversity of California San Diego, Department of Neurosciences, La Jolla, CA 92093, USA.
Tiziano PramparoUniversity of California San Diego, Department of Neurosciences, La Jolla, CA 92093, USA.
Lisa EylerUniversity of California San Diego, Department of Neurosciences, La Jolla, CA 92093, USA.
Cynthia C BarnesUniversity of California San Diego, Department of Neurosciences, La Jolla, CA 92093, USA.
Eric CourchesneUniversity of California San Diego, Department of Neurosciences, La Jolla, CA 92093, USA.
Daniel H GeschwindUniversity of California Los Angeles, Program in Neurogenetics, Department of Neurology, Center for Autism Research and Treatment, Semel Institute, David Geffen School of Medicine, Los Angeles, CA 90402, USA.
Fred H GageThe Salk Institute, Laboratory of Genetics, La Jolla, CA 92037, USA.
Anthony Wynshaw-BorisUniversity of California San Francisco, Department of Pediatrics, Institute for Human Genetics, CA 94143, USA.
Alysson R MuotriUniversity of California San Diego, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular & Molecular Medicine, Stem Cell Program, La Jolla, CA 92093-0695, USA.
University of California San Diego · USSalk Institute for Biological Studies · USUniversity of California, Los Angeles · USUniversity of California, San Francisco · USCase Western Reserve University · USIcahn School of Medicine at Mount Sinai · USUniversity of Rochester · US

Funding

Single-cell approaches to deconvolution of disease-associated signalsU19MH107367 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CALLAWAY, EDWARD M · 2015 to 2019
$15.0M
Supplemental Training in Making Data FAIR and AI/ML ReadyT32ES007322 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Pam R Factor-Litvak, Allison Kupsco · 2000 to 2026
$12.1M
Proteogenetics of Autism Spectrum DisordersR01MH100175 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI MUOTRI, ALYSSON R., YATES III, JOHN R · 2013 to 2025
$7.4M
Modeling autism with human pluripotent cellsDP2OD006495 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MUOTRI, ALYSSON R. · 2009 to 2009
$2.3M
in vivo imaging of transplanted human induced-Pluripotent Stem Cell (iPSC) derived neurons to model neurological and psychiatric disordersR01MH113924 · NIMH · UNIVERSITY OF ROCHESTER · PI PADMANABHAN, KRISHNAN · 2017 to 2021
$2.3M
The Impact of L1retrotransposition in the nervous systemR01MH094753 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MUOTRI, ALYSSON R. · 2011 to 2015
$1.9M
San Diego Clinical and Translational Research InstituteKL2TR000099 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2012 to 2014
$1.1M
ENGRAFTING HUMAN NEURONS INTO ANIMAL MODELS TO STUDY SCHIZOPHRENIAR00MH101634 · NIMH · UNIVERSITY OF ROCHESTER · PI PADMANABHAN, KRISHNAN · 2016 to 2018
$731k
NCATS NIH HHS KL2 TR000099NIEHS NIH HHS T32 ES007322NIH HHS DP2 OD006495NIMH NIH HHS R00 MH101634NIMH NIH HHS R01 MH094753NIMH NIH HHS R01 MH100175NIMH NIH HHS R01 MH113924NIMH NIH HHS U19 MH107367
6 · The paper itself

Abstract

Autism spectrum disorders (ASD) are common, complex and heterogeneous neurodevelopmental disorders. Cellular and molecular mechanisms responsible for ASD pathogenesis have been proposed based on genetic studies, brain pathology and imaging, but a major impediment to testing ASD hypotheses is the lack of human cell models. Here, we reprogrammed fibroblasts to generate induced pluripotent stem cells, neural progenitor cells (NPCs) and neurons from ASD individuals with early brain overgrowth and non-ASD controls with normal brain size. ASD-derived NPCs display increased cell proliferation because of dysregulation of a β-catenin/BRN2 transcriptional cascade. ASD-derived neurons display abnormal neurogenesis and reduced synaptogenesis leading to functional defects in neuronal networks. Interestingly, defects in neuronal networks could be rescued by insulin growth factor 1 (IGF-1), a drug that is currently in clinical trials for ASD. This work demonstrates that selection of ASD subjects based on endophenotypes unraveled biologically relevant pathway disruption and revealed a potential cellular mechanism for the therapeutic effect of IGF-1.

Indexed as

AdolescentAutism Spectrum DisorderAutistic Disorderbeta CateninBrainCell ProliferationCells, CulturedChildChild, PreschoolFemaleFibroblastsHumansInduced Pluripotent Stem CellsInsulin-Like Growth Factor IMaleNeural Stem Cellsbeta CateninInsulin-Like Growth Factor I

Identifiers

PMID27378147
PMCPMC5215991
OpenAlexW2461476914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.